Goldman Sachs Group »

Silence Therapeutics shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $309k 16k 19.00
2024-03-31 $470k 22k 21.60
2023-09-30 $2.6M 267k 9.82
2023-06-30 $2.3M 410k 5.50
2023-03-31 $4.1M 660k 6.20
2022-12-31 $10M 660k 15.25
2022-06-30 $7.8M 660k 11.85
2022-03-31 $18M 966k 19.00
2021-12-31 $18M 760k 23.89